An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory Uveitis
NCT07773623
Eye Diseases, Uveal Diseases
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT Number: NCT05385757
Childhood uveitis (inflammation inside the eye) is an uncommon disorder that carries the risk of blindness. Inadequate treatment of active inflammation has been shown to be related to a poor outcome. There has been no population-based, prospective longitudinal study of all-cause childhood uveitis, with resultant limitations in the evidence base used to counsel affected families, balance treatment decisions, or plan further research. The aim of the study is to describe the characteristics of childhood-onset uveitis and describe outcomes. The investigators shall also aim to identify the socio-demographic, clinical, biological and treatment-related determinants of outcome. Early (1-2 years following diagnosis) outcomes will be described in the first instance: However, through the creation of a national inception cohort, the investigators shall enable longer-term studies of outcome for affected children and families. There will be no change to routine clinical care.
This study is active but is not currently recruiting participants.
Notify MeUp to 18 year
All sexes
Observational
Belfast Royal Victoria Hospital NHS Foundation Trust, Belfast, United Kingdom
Background:
Childhood uveitis descriptive term for a group of rare inflammatory eye disease, which are typically chronic, relapsing-remitting in nature, and of uncertain aetiology (idiopathic). Visual loss occurs due to structural damage caused by uncontrolled inflammation. Understanding of the determinants of long-term outcome is limited, particularly the predictors of therapeutic response or how to define disease control.
Aims:
To describe disease natural history and outcomes amongst a nationally representative group of children with non-infectious uveitis, describe the impact of disease course on quality of life for both child and family, and identify determinants of adverse visual, structural and developmental outcomes.
Methods:
UNICORNS is a prospective longitudinal multicentre cohort study of children newly diagnosed with uveitis about whom a core minimum clinical dataset will be collected. Participants and their families will also complete patient-reported outcome measures (PROMS) at study entry and annually from recruitment.
PROMS collected at baseline are:
PROMS collected at year 1 and annually (subject to investigations of instrument redundancy) are:
Discussion:
Through this population based, prospective longitudinal study of childhood uveitis, the investigators will describe the characteristics of childhood onset disease. Early (1-2 years following diagnosis) outcomes will be described in the first instance, and through the creation of a national inception cohort, longer term studies of outcome for affected children and families will be enabled.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 3 years
New incident of sight threatening ocular complications, including glaucoma, cataract and macular oedema
Time frame: Up to 3 years
Quality of life (patient reported outcomes) using Pediatric Quality of Life Inventory (PedsQL) in which items are reversed scored and linearly transformed to a 0-100 scale, so that higher scores indicate better HRQOL (Health-Related Quality of Life)
Time frame: Up to 3 years
Total prescribed topical and systemic corticosteroid burden
Time frame: Up to 3 years
Number of children achieving absolute control defined as absence of inflammation Relative control defined as the absence of inflammation greater than 0.5 The lowest grade of inflammation, with the use of less than one drop of topical corticosteroid
Time frame: Up to 3 years
Child Health Utility Metric (CHU9D), with scores ranging from 0.33 (worst health state) to 1.00 (best health state)
Time frame: Over one year from baseline to year one
Change in child reported quality of life using Pediatric Quality of Life Inventory (PedsQL) in which items are reversed scored and linearly transformed to a 0-100 scale, so that higher scores indicate better HRQOL (Health-Related Quality of Life), and a change of greater than 5 is clinically meaningful
This study is active but is not currently recruiting participants.
Notify MeInstitute of Child Health
Other
Uveitis in Childhood Prospective National Cohort Study
Acronym: UNICORNS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07773623
Eye Diseases, Uveal Diseases
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT04088409
Eye Diseases, Uveal Diseases
Le Kremlin-Bicêtre, France
View Trial DetailsNCT04704609
Eye Diseases, Uveal Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT06431373
Eye Diseases, Panuveitis
Phoenix, Arizona, United States
View Trial Details